期刊文献+

内皮细胞特异性分子1与脑动脉粥样硬化程度及大动脉粥样硬化型脑梗死预后的关系 被引量:7

Relationship of endothelial specific molecular 1with cerebral atherosclerosis and prognosis of LAA cerebral infarction
下载PDF
导出
摘要 目的探讨内皮细胞特异性分子(Endocan)与脑动脉粥样硬化(AS)广泛程度及大动脉粥样硬化型(LAA)脑梗死患者预后的关系。方法选择脑梗死患者155例,按照TOAST分型分为LAA组105例,小动脉闭塞型(SAO)组50例,同期另选无症状脑动脉狭窄患者33例为无症状狭窄组,健康对照者60例为对照组。将LAA组按AS病变分为单支、双支、多支病变。用ELISA血浆Endocan水平。LAA组随访3个月,行改良Rankin量表(mRS)评分,用ROC曲线评估Endocan对LAA脑梗死患者预后的预测价值。结果 LAA组血浆Endocan水平(1.29±0.40)μg/L,SAO组(1.01±0.32)μg/L,无症状狭窄组(1.26±0.38)μg/L,对照组(1.00±0.31)μg/L,LAA组高于SAO组和对照组(P<0.01),无症状狭窄组高于SAO组和对照组(P<0.01)。LAA组多支、双支、单支病变血浆Endocan水平有显著差异(P<0.05,P<0.01)。LAA组患者血浆Endocan水平与mRS评分及AS广泛程度呈正相关(P=0.000),Endocan判断预后的ROC曲线下面积为0.652。结论血浆Endocan水平与AS广泛程度相关,有潜力成为评价AS广泛程度和判断LAA脑梗死患者预后的血浆标记物。 objective To study the relationship of endothelial specific molecular 1(Endocan)with the severity of cerebral atherosclerosis and the prognosis of LAA cerebral infarction(CI).Methods 155 CI patients were divided into LAA group(n=105),SAO group(n=50),an additional33 patients with asymptomatic cerebral artery stenosis served as an asymptomatic stenosis group and 60 healthy persons served as a control group in this study.Patients in LAA group were further divided into single lesion group,double lesion group,and multiple lesion group.Their serum Endocan level was measured.Patients in LAA group were followed up for 3 months and scored according to the mRS.Role of serum Endocan level in predicting the prognosis of LAA CI patients was assessed according to the ROC curve.Results The serum Endocan level is significantly higher in LAA group than in SAO group and control group,and in asymptomatic stenosis group than in SAO group and control group(P〈0.01).The serum Endocan level was positively related with the mRS score in LAA group(P=0.000).The serum Endocan level among three subgroups was statistically different(P〈0.01).The area under the ROC curve was 0.652.Conclusion Serum Endocan level is related with the severity of cerebral atherosclerosis and can thus be used as a plasma marker for assessing the severity of atherosclerosis and the prognosis of LAA CI patients.
出处 《中华老年心脑血管病杂志》 CAS 2016年第7期711-714,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 国家自然科学基金(81571112)
关键词 内皮细胞 动脉粥样硬化 脑梗死 肌细胞 平滑肌 endothelial cells atherosclerosis brain infarction myocytes smooth muscle
  • 相关文献

参考文献18

  • 1吴丽娥,刘鸣,张月辉,赵晓玲,杨杰,谈颂,张世洪,吴波,谭燕,王清芳,王丽春,李伟.缺血性脑卒中TOAST病因分型和预后[J].中华神经科杂志,2004,37(4):292-295. 被引量:87
  • 2Kriszbacher I,Koppan M,Bódis J,et al.Inflammation,atherosclerosis,and coronary artery disease[J].N Engl J Med,2005,353:429-430.
  • 3Balta S,Demirkol S,Celik T,et al.Association between coronary artery ectasia and neutrophil-lymphocyte ratio.Angiology,2013,64:627-632.
  • 4Zhang SM,Zuo L,Zhou Q,et al.Expression and distribution of endocan in human tissue[J].Biotech Histochem,2012,87:172-178.
  • 5刘雅,张蓓,刘洁琳,温绍君.内皮细胞特异性分子1与内皮细胞功能异常疾病[J].中华老年心脑血管病杂志,2015,17(6):655-657. 被引量:9
  • 6Lee W,Ku SK,Kim SW,et al.Endocan elicits severe vascular inflammatory responses in vitro and in vivo.J Cell Physiol,2014,229:620-630.
  • 7Scherpereel A,Depontieu F,Grigoriu B,et al.Endocan,a new endothelial marker in human sepsis.Crit Care Med,2006,34:532-537.
  • 8Pauly D,Hamed S,Behnes M,et al.Endothelia cell-specific molecule-1/endocan:diagnostic and prognostic value in patients suffering from severe sepsis and septic shock.J Crit Care,2016,31:68-75.
  • 9Balta I,Balta S,Koryurek OM,et al.Serum endocan levels as a marker of disease activity in patients with Behcet disease.J Am Acad Dermatol,2014,70:291-296.
  • 10Menon P,Kocher ON,Aird WC,et al.Endothelia cell specific molecule(ESM-1),a novel secreted proteoglycan stimulates vascular smooth muscle cell proliferation and migration.Circulation,2011,124:154-155.

二级参考文献45

  • 1周小英,黄勇华,张微微.不同类型脑梗死患者血清C反应蛋白水平的变化及临床意义[J].中华老年心脑血管病杂志,2006,8(3):151-153. 被引量:19
  • 2Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 1993, 24: 35-41.
  • 3Kristensen B, Malm J, Carlberg B, et al. Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in Northern Sweden. Stroke, 1997, 28: 1702-1709.
  • 4Kolominsky-Rabas PL, Weber M, Gefeller O, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria. Stroke, 2001,32: 2735-2740.
  • 5Lee BI, Nam HS, Heo JH, et al. Yonsei stroke registry: analysis of 1000 patients with acute cerebral infarction. Cerebrovasc Dis, 2001,12: 145-151.
  • 6Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinical subtypes of cerebral infarction. Lancet,1991, 337:1521-1526.
  • 7WHO Special Report. Stroke: recommendations on stroke prevention, diagnosis and therapy. Stroke, 1989, 20:1407-1431.
  • 8Mahoney FD, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J, 1965,14:61-63.
  • 9PROGRESS Collaborative Group. Randomised trial of a perindoprilbased blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet, 2001,358:1033-1041.
  • 10Kunitz SC, Gross CR, Heyman A, et al. The pilot Stroke Data Bank: definition, design, and data. Stroke, 1984, 15:740-746.

共引文献135

同被引文献39

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部